Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
Vadhan-Raj
S
S
Department of Clinical Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Broxmeyer
H E
HE
Hittelman
W N
WN
D000740:Anemia / Q000209:etiology / Q000628:therapy; D000741:Anemia, Aplastic / Q000628:therapy; D000818:Animals; D002908:Chronic Disease; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000628:therapy*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000628:therapy; D009503:Neutropenia / Q000628:therapy; D010198:Pancytopenia / Q000209:etiology / Q000628:therapy; D011832:Radiation Injuries / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor